Schott to Invest in China

The German technology group Schott AG is looking to extend its presence in the Asian growth market. The company has laid the cornerstone for another pharmaceutical packaging plant that will be located south of Shanghai. Starting in 2017, glass packaging for injectable drugs will be manufactured here, in particular vials and ampoules. Furthermore, the Schott Group also plans to modernise and expand its existing facilities at its integrated site in Suzhou. The Pharmaceutical Systems division of Schott will invest approx. €30 million in total in China over the next three years. These measures will increase the company’s production capacity by 50% over the same period.

With this expansion, the company is paying tribute to the strong growth of the Chinese pharmaceutical market. Schott serves this market from two production facilities – a plant in Suzhou, which is an integrated production facility of the Schott Group, and through its joint venture with Schott Xinkang. The new production facility will be built at the site of Schott Xinkang’s headquarters in Jinyun.